Transcriptome changes during peanut oral immunotherapy and omalizumab treatment

Sophia Björkander; Simon Kebede Merid; David Brodin; Josef Brandström; Fredrik Fagerström-Billai; Marieke van der Heiden; Jon R. Konradsen; Michael Kabesch; Cornelis M. van Drunen; Korneliusz Golebski; Anke H. Maitland-van der Zee; Uroš Potočnik; Susanne J. H. Vijverberg; Anna Nopp; Caroline Nilsson; Erik Melén

doi:10.1111/pai.13682

Transcriptome changes during peanut oral immunotherapy and omalizumab treatment

Sophia Björkander
, Simon Kebede Merid
, David Brodin
, Josef Brandström
, Fredrik Fagerström-Billai
, Marieke van der Heiden
, Jon R. Konradsen
, Michael Kabesch
, Cornelis M. van Drunen
, Korneliusz Golebski
, Anke H. Maitland-van der Zee
, Uroš Potočnik
, Susanne J. H. Vijverberg
, Anna Nopp
, Caroline Nilsson
, Erik Melén^*

^*Corresponding author for this work

Karolinska Institutet
University of Groningen, University Medical Center Groningen
Department of Pediatric Neurology, Klinik St Hedwig, University Children’s Hospital Regensburg (KUNO), Regensburg, Germany
University of Amsterdam
Center for Human Molecular Genetics and Pharmacogenomics, Slovenia
University of Maribor
Sachs' Children and Youth Hospital, Sweden

Research output: Contribution to journal › Comment/Letter to the editor › Academic

27 Downloads (Pure)

Original language	English
Article number	e13682
Journal	Pediatric allergy and immunology
Volume	33
Issue number	1
Early online date	2021
DOIs	https://doi.org/10.1111/pai.13682
Publication status	Published - Jan 2022

Access to Document

10.1111/pai.13682

Transcriptome-changes-during-peanut-oral-immunotherapy-and-omalizumab-treatment.pdfFinal published version, 547 KB

Cite this

Björkander, S., Merid, S. K., Brodin, D., Brandström, J., Fagerström-Billai, F., van der Heiden, M., Konradsen, J. R., Kabesch, M., van Drunen, C. M., Golebski, K., Maitland-van der Zee, A. H., Potočnik, U., Vijverberg, S. J. H., Nopp, A., Nilsson, C., & Melén, E. (2022). Transcriptome changes during peanut oral immunotherapy and omalizumab treatment. Pediatric allergy and immunology, 33(1), Article e13682. https://doi.org/10.1111/pai.13682

@article{182383cde8314227a58d86d208574802,

title = "Transcriptome changes during peanut oral immunotherapy and omalizumab treatment",

author = "Sophia Bj{\"o}rkander and Merid, \{Simon Kebede\} and David Brodin and Josef Brandstr{\"o}m and Fredrik Fagerstr{\"o}m-Billai and \{van der Heiden\}, Marieke and Konradsen, \{Jon R.\} and Michael Kabesch and \{van Drunen\}, \{Cornelis M.\} and Korneliusz Golebski and \{Maitland-van der Zee\}, \{Anke H.\} and Uro{\v s} Poto{\v c}nik and Vijverberg, \{Susanne J. H.\} and Anna Nopp and Caroline Nilsson and Erik Mel{\'e}n",

note = "Funding Information: The PERMEABLE consortium supported by ZonMW (456008004), the Swedish Research Council (2018‐05619), the Ministry of Education, Science and Sport of the Republic of Slovenia (C3330‐19‐252012) and the German Ministry of Education and Research (BMBF) (FKZ01KU1909A), under the frame of the ERA PerMed JTC 2018 Call. Additional funding in the Online Appendix.",

year = "2022",

month = jan,

doi = "10.1111/pai.13682",

language = "English",

volume = "33",

journal = "Pediatric allergy and immunology",

issn = "0905-6157",

publisher = "Blackwell Munksgaard",

number = "1",

}

Björkander, S, Merid, SK, Brodin, D, Brandström, J, Fagerström-Billai, F, van der Heiden, M, Konradsen, JR, Kabesch, M, van Drunen, CM , Golebski, K , Maitland-van der Zee, AH, Potočnik, U, Vijverberg, SJH, Nopp, A, Nilsson, C & Melén, E 2022, 'Transcriptome changes during peanut oral immunotherapy and omalizumab treatment', Pediatric allergy and immunology, vol. 33, no. 1, e13682. https://doi.org/10.1111/pai.13682

TY - JOUR

T1 - Transcriptome changes during peanut oral immunotherapy and omalizumab treatment

AU - Björkander, Sophia

AU - Merid, Simon Kebede

AU - Brodin, David

AU - Brandström, Josef

AU - Fagerström-Billai, Fredrik

AU - van der Heiden, Marieke

AU - Konradsen, Jon R.

AU - Kabesch, Michael

AU - van Drunen, Cornelis M.

AU - Golebski, Korneliusz

AU - Maitland-van der Zee, Anke H.

AU - Potočnik, Uroš

AU - Vijverberg, Susanne J. H.

AU - Nopp, Anna

AU - Nilsson, Caroline

AU - Melén, Erik

N1 - Funding Information: The PERMEABLE consortium supported by ZonMW (456008004), the Swedish Research Council (2018‐05619), the Ministry of Education, Science and Sport of the Republic of Slovenia (C3330‐19‐252012) and the German Ministry of Education and Research (BMBF) (FKZ01KU1909A), under the frame of the ERA PerMed JTC 2018 Call. Additional funding in the Online Appendix.

PY - 2022/1

Y1 - 2022/1

UR - https://www.scopus.com/pages/publications/85118262007

U2 - 10.1111/pai.13682

DO - 10.1111/pai.13682

M3 - Comment/Letter to the editor

C2 - 34669990

SN - 0905-6157

VL - 33

JO - Pediatric allergy and immunology

JF - Pediatric allergy and immunology

IS - 1

M1 - e13682

ER -

Transcriptome changes during peanut oral immunotherapy and omalizumab treatment

Access to Document

Other files and links

Cite this